PARDEE FOUNDATION - GRANT RECIPIENTS

Example of Recent Research Grants (2009)

	Advances in cancer treatment technologies depend on research support.

University of Alabama - $51,823 for the study of infiltrating suppressive gamma/delta T cells in glioblastoma.

Dartmouth Medical School - $162,888 for the study of targeting cancer recurrence via disruption of tumor stem cell quiescence.

Georgetown University - $125,000 for pilot studies on novel BRCA1-mimetic compounds to inhibit estrogen receptor function in breast cancer.

InMotion Orthopaedic Research Center - $111,019 for the study of the efficacy of a paclitaxel eluting fibrin biomatrix in treating skeletal metastases.

Joan & Sanford I Weill Medical College at Cornell University - $146,066 for the study of radiolabeled anti-PSMA monoclonal antibody to target non-prostate solid tumor neovasculature.

Memorial Sloan-Kettering Cancer Center - $125,000 for the study of the contribution of cell type-specific circuitry to retinoblastoma tumorigenesis.

University of North Carolina - $109,708 for the study of the protein palladin as a biomarker for detection of pancreatic cancer.

State University of New York at Buffalo - $118,856 for the study of synthesis and biological evaluation of stapled peptide helices as novel anti-cancer agents.